抽搐性运动障碍

Murphy TK, Lewin AB, Storch EA, et al. Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry. 2013 Dec;52(12):1341-59.全文  摘要

Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May 7;92(19):896-906.全文  摘要

Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May 7;92(19):907-15.全文  摘要

Kuo SH, Jimenez-Shahed J. Topiramate in treatment of Tourette syndrome. Clin Neuropharmacol. 2010 Jan-Feb;33(1):32-4. 摘要

Bloch MH, Panza KE, Landeros-Weisenberger A, et al. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):884-93.全文  摘要

1. Jankovic J, Lang AE. Movement disorders: diagnosis and assessment. In: Bradley WG, Daroff RB, Fenichel GM, et al. Neurology in clinical practice. Principles of diagnosis and management. 4th ed. Philadelphia, PA: Elsevier; 2004:313-5.

2. Singer HS. Tourette syndrome and its associated neurobehavioral problems. In: Swaiman KF, Ashwal S, Ferriero DM. Pediatric neurology: principles and practice. 4th ed. Philadelphia, PA: Elsevier; 2006:887-98.

3. Fahn S, Jankovic J. Principles and practice of movement disorders. Philadelphia, PA: Elsevier; 2007:409-33.

4. Knight T, Steeves T, Day L, et al. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol. 2012 Aug;47(2):77-90. 摘要

5. Leivonen S, Voutilainen A, Hinkka-Yli-Salomäki S, et al. A nationwide register study of the characteristics, incidence and validity of diagnosed Tourette syndrome and other tic disorders. Acta Paediatr. 2014 Sep;103(9):984-90. 摘要

6. Scahill L, Specht M, Page C. The prevalence of tic disorders and clinical characteristics in children. J Obsessive Compuls Relat Disord. 2014 Oct 1;3(4):394-400.全文  摘要

7. Black KJ, Black ER, Greene DJ, et al. Provisional tic disorder: what to tell parents when their child first starts ticcing. F1000Res. 2016 Apr 18;5:696.全文  摘要

8. Alves HL, Quagliato EM. The prevalence of tic disorders in children and adolescents in Brazil. Arq Neuropsiquiatr. 2014 Dec;72(12):942-8.全文  摘要

9. Scharf JM, Miller LL, Gauvin CA, et al. Population prevalence of Tourette syndrome: a systematic review and meta-analysis. Mov Disord. 2015 Feb;30(2):221-8. 摘要

10. Bitsko RH, Holbrook JR, Visser SN, et al. A national profile of Tourette syndrome, 2011-2012. J Dev Behav Pediatr. 2014 Jun;35(5):317-22.全文  摘要

11. Centers for Disease Control and Prevention (CDC). Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years – United States, 2007. MMWR Morb Mortal Wkly Rep. 2009 Jun 5;58(21):581-5.全文  摘要

12. Singer HS. Treatment of tics and Tourette syndrome. Curr Treat Options Neurol. 2010 Nov;12(6):539-61. 摘要

13. Murphy TK, Lewin AB, Storch EA, et al. Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry. 2013 Dec;52(12):1341-59.全文  摘要

14. Leckman J, Block M, King R, et al. Phenomenology of tics and natural history of tic disorders. Adv Neurol. 2006;99:1-16. 摘要

15. Murphy TK, Kurlan R, Leckman J. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol. 2010 Aug;20(4):317-31.全文  摘要

16. Centorino MB, Catalano G, Catalano MC. Lamotrigine induced whole body tics: a case report and literature review. Curr Drug Saf. 2016;11(2):189-91. 摘要

17. Shavitt RG, Hounie AG, Rosario Campos MC, et al. Tourette's syndrome. Psychiatr Clin North Am. 2006 Jun;29(2):471-86. 摘要

18. Nespoli E, Rizzo F, Boeckers TM, et al. Addressing the complexity of Tourette's syndrome through the use of animal models. Front Neurosci. 2016 Apr 8;10:133.全文  摘要

19. Frick L, Pittenger C. Microglial dysregulation in OCD, Tourette syndrome, and PANDAS. J Immunol Res. 2016;2016:8606057.全文  摘要

20. Israelashvili M, Bar-Gad I. Corticostriatal divergent function in determining the temporal and spatial properties of motor tics. J Neurosci. 2015 Dec 16;35(50):16340-51.全文  摘要

21. Worbe Y, Marrakchi-Kacem L, Lecomte S, et al. Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome. Brain. 2015 Feb;138(Pt 2):472-82.全文  摘要

22. Zapparoli L, Porta M, Gandola M, et al. A functional magnetic resonance imaging investigation of motor control in Gilles de la Tourette syndrome during imagined and executed movements. Eur J Neurosci. 2016 Feb;43(4):494-508. 摘要

23. Plessen KJ, Bansal R, Peterson BS. Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res. 2009 Dec;67(6):559-73.全文  摘要

24. Greene DJ, Williams Iii AC, Koller JM, et al. Brain structure in pediatric Tourette syndrome. Mol Psychiatry. 2017 Jul;22(7):972-80.全文  摘要

25. Zapparoli L, Tettamanti M, Porta M, et al. A tug of war: antagonistic effective connectivity patterns over the motor cortex and the severity of motor symptoms in Gilles de la Tourette syndrome. Eur J Neurosci. 2017 Sep;46(6):2203-13. 摘要

26. Fernandez TV, Sanders SJ, Yurkiewicz IR, et al. Rare copy number variants in Tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry. 2012 Mar 1;71(5):392-402.全文  摘要

27. Rapanelli M, Pittenger C. Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions. Neuropharmacology. 2016 Jul;106:85-90. 摘要

28. Yang X, Liu W, Yi M, et al. Choline acetyltransferase may contribute to the risk of Tourette syndrome: combination of family-based analysis and case-control study. World J Biol Psychiatry. 2017 Feb 14:1-6. 摘要

29. Abdulkadir M, Londono D, Gordon D, et al. Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approach. Eur Arch Psychiatry Clin Neurosci. 2018 Apr;268(3):301-16.全文  摘要

30. Hirschtritt ME, Darrow SM, Illmann C, et al. Genetic and phenotypic overlap of specific obsessive-compulsive and attention-deficit/hyperactive subtypes with Tourette syndrome. Psychol Med. 2018 Jan;48(2):279-93. 摘要

31. Müller-Vahl KR, Loeber G, Kotsiari A, et al. Gilles de la Tourette syndrome is associated with hypermethylation of the dopamine D2 receptor gene. J Psychiatr Res. 2017 Mar;86:1-8.全文  摘要

32. Dalsgaard S, Waltoft BL, Leckman JF, et al. Maternal history of autoimmune disease and later development of Tourette syndrome in offspring. J Am Acad Child Adolesc Psychiatry. 2015 Jun;54(6):495-501. 摘要

33. Murphy TK, Storch EA, Turner A, et al. Maternal history of autoimmune disease in children presenting with tics and/or obsessive-compulsive disorder. J Neuroimmunol. 2010 Dec 15;229(1-2):243-7.全文  摘要

34. Cardona F, Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr. 2001 Jan;138(1):71-5. 摘要

35. Wang HC, Lau CI, Lin CC, et al. Group A streptococcal infections are associated with increased risk of pediatric neuropsychiatric disorders: a Taiwanese population-based cohort study. J Clin Psychiatry. 2016 Jul;77(7):e848-54. 摘要

36. Swedo SE, Leckman JF, Rose NR. From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome). Pediatr Therapeut. 2012;2:113.全文

37. Singer HS, Gilbert DL, Wolf DS, et al. Moving from PANDAS to CANS. J Pediatr. 2012 May;160(5):725-31. 摘要

38. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

39. Janik P, Kalbarczyk A, Sitek M. Clinical analysis of Gilles de la Tourette syndrome based on 126 cases. Neurol Neurochir Pol. 2007 Sep-Oct;41(5):381-7. 摘要

40. Mataix-Cols D, Isomura K, Pérez-Vigil A, et al. Familial risks of Tourette syndrome and chronic tic disorders: a population-based cohort study. JAMA Psychiatry. 2015 Aug;72(8):787-93.全文  摘要

41. Freeman RD, Fast DK, Burd L, et al. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol. 2000 Jul;42(7):436-47.全文  摘要

42. Khalifa N, von Knorring AL. Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background. Acta Paediatr. 2005 Nov;94(11):1608-14. 摘要

43. Leivonen S, Scharf JM, Mathews CA, et al. Parental psychopathology and Tourette syndrome/chronic tic disorder in offspring: a nationwide case-control study. J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):297-303. 摘要

44. Browne HA, Modabbernia A, Buxbaum JD, et al. Prenatal maternal smoking and increased risk for Tourette syndrome and chronic tic disorders. J Am Acad Child Adolesc Psychiatry. 2016 Sep;55(9):784-91.全文  摘要

45. Mathews CA, Bimson B, Lowe TL, et al. Association between maternal smoking and increased symptom severity in Tourette's syndrome. Am J Psychiatry. 2006 Jun;163(6):1066-73. 摘要

46. Hirschtritt ME, Lee PC, Pauls DL, et al; Tourette Syndrome Association International Consortium for Genetics. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry. 2015 Apr;72(4):325-33.全文  摘要

47. Brainstorm Consortium, Anttila V, Bulik-Sullivan B, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018 Jun 22;360(6395):eaap8757. 摘要

48. Darrow SM, Grados M, Sandor P, et al. Autism spectrum symptoms in a Tourette's disorder sample. J Am Acad Child Adolesc Psychiatry. 2017 Jul;56(7):610-7.全文  摘要

49. Stephens RJ, Chung SA, Jovanovic D, et al. Relationship between polysomnographic sleep architecture and behavior in medication-free children with TS, ADHD, TS and ADHD, and controls. J Dev Behav Pediatr. 2013 Nov-Dec;34(9):688-96. 摘要

50. Lee WT, Huang HL, Wong LC, et al. Tourette syndrome as an independent risk factor for subsequent sleep disorders in children: a nationwide population-based case-control study. Sleep. 2017 Mar 1;40(3).全文  摘要

51. Greenberg E, Tung ES, Gauvin C, et al. Prevalence and predictors of hair pulling disorder and excoriation disorder in Tourette syndrome. Eur Child Adolesc Psychiatry. 2018 May;27(5):569-79. 摘要

52. Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May 7;92(19):896-906.全文  摘要

53. Rizzo R, Pellico A, Silvestri PR, et al. A randomized controlled trial comparing behavioral, educational, and pharmacological treatments in youths with chronic tic disorder or tourette syndrome. Front Psychiatry. 2018 Mar 27;9:100.全文  摘要

54. Sukhodolsky DG, Woods DW, Piacentini J, et al. Moderators and predictors of response to behavior therapy for tics in Tourette syndrome. Neurology. 2017 Mar 14;88(11):1029-36.全文  摘要

55. Whittington C, Pennant M, Kendall T, et al. Practitioner review: treatments for Tourette syndrome in children and young people - a systematic review. J Child Psychol Psychiatry. 2016 Sep;57(9):988-1004. 摘要

56. Bennett SM, Capriotti M, Bauer C, et al. Development and open trial of a psychosocial intervention for young children with chronic tics: the CBIT-JR study. Behav Ther. 2020 Jul;51(4):659-69. 摘要

57. Dutta N, Cavanna AE. The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review. Funct Neurol. 2013 Jan-Mar;28(1):7-12.全文  摘要

58. Rizwan M, Shahid NUA, Naguit N, et al. Efficacy of behavioural intervention, antipsychotics, and alpha agonists in the treatment of tics disorder in Tourette's syndrome. Cureus. 2022 Feb;14(2):e22449.全文  摘要

59. Fründt O, Woods D, Ganos C. Behavioral therapy for Tourette syndrome and chronic tic disorders. Neurol Clin Pract. 2017 Apr;7(2):148-56. 摘要

60. Hollis C, Hall CL, Jones R, et al. Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised controlled trial. Lancet Psychiatry. 2021 Oct;8(10):871-82.全文  摘要

61. Ricketts EJ, Gilbert DL, Zinner SH, et al. Pilot testing behavior therapy for chronic tic disorders in neurology and developmental pediatrics clinics. J Child Neurol. 2016 Mar;31(4):444-50. 摘要

62. Frank M, Cavanna AE. Behavioural treatments for Tourette syndrome: an evidence-based review. Behav Neurol. 2013;27(1):105-17.全文  摘要

63. McGuire JF, Piacentini J, Brennan EA, et al. A meta-analysis of behavior therapy for Tourette syndrome. J Psychiatr Res. 2014 Mar;50:106-12. 摘要

64. Weisman H, Qureshi IA, Leckman JF. Systematic review: pharmacological treatment of tic disorders - efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev. 2013 Jul;37(6):1162-71.全文  摘要

65. Waldon K, Hill J, Termine C, et al. Trials of pharmacological interventions for Tourette syndrome: a systematic review. Behav Neurol. 2013;26(4):265-73.全文  摘要

66. Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May 7;92(19):907-15.全文  摘要

67. Marras C, Andrews D, Sime E, et al. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology. 2001 Mar 13;56(5):605-10. 摘要

68. Pandey S, Srivanitchapoom P, Kirubakaran R, et al. Botulinum toxin for motor and phonic tics in Tourette's syndrome. Cochrane Database Syst Rev. 2018 Jan 5;1:CD012285.全文  摘要

69. Budman CL. The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview. Drugs. 2014 Jul;74(11):1177-93. 摘要

70. Yang C, Hao Z, Zhang LL, et al. Comparative efficacy and safety of antipsychotic drugs for tic disorders: a systematic review and Bayesian network meta-analysis. Pharmacopsychiatry. 2019 Jan;52(1):7-15.全文  摘要

71. Mogwitz S, Buse J, Ehrlich S, et al. Clinical pharmacology of dopamine-modulating agents in Tourette's syndrome. Int Rev Neurobiol. 2013;112:281-349. 摘要

72. Wijemanne S, Wu LJ, Jankovic J. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov Disord. 2014 Jan;29(1):126-30. 摘要

73. Kenney C, Kuo SH, Jimenez-Shahed J. Tourette's syndrome. Am Fam Physician. 2008 Mar 1;77(5):651-8.全文  摘要

74. Preskorn SH. Changes in the product label for pimozide illustrate both the promises and the challenges of personalized medicine. J Clin Psychiatry. 2012 Sep;73(9):1191-3.全文  摘要

75. Kuo SH, Jimenez-Shahed J. Topiramate in treatment of Tourette syndrome. Clin Neuropharmacol. 2010 Jan-Feb;33(1):32-4. 摘要

76. Yang CS, Zhang LL, Zeng LN, et al. Topiramate for Tourette's syndrome in children: a meta-analysis. Pediatr Neurol. 2013 Nov;49(5):344-50. 摘要

77. Pringsheim T, Doja A, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Can J Psychiatry. 2012 Mar;57(3):133-43. 摘要

78. Singer HS, Wendlandt J, Krieger M, et al. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology. 2001 Mar 13;56(5):599-604. 摘要

79. Gonce M, Barbeau A. Seven cases of Gilles de la Tourette's syndrome: partial relief with clonazepam: a pilot study. Can J Neurol Sci. 1977 Nov;4(4):279-83. 摘要

80. Fasano A, Bentivoglio AR. Tetrabenazine. Expert Opin Pharmacother. 2009 Dec;10(17):2883-96. 摘要

81. Porta M, Sassi M, Cavallazzi M, et al. Tourette's syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig. 2008;28(7):443-59. 摘要

82. Guay DR. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Am J Geriatr Pharmacother. 2010 Aug;8(4):331-73. 摘要

83. Farber RH, Angelov A, Kim K, et al. Clinical development of valbenazine for tics associated with Tourette syndrome. Expert Rev Neurother. 2021 Apr;21(4):393-404.全文  摘要

84. Rizzo R, Gulisano M, Cali PV, et al. Tourette syndrome and comorbid ADHD: current pharmacological treatment options. Eur J Paediatr Neurol. 2013 Sep;17(5):421-8. 摘要

85. Osland ST, Steeves TD, Pringsheim T. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev. 2018 Jun 26;(6):CD007990.全文  摘要

86. Bloch MH, Panza KE, Landeros-Weisenberger A, et al. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):884-93.全文  摘要

87. Veale D, Miles S, Smallcombe N, et al. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychiatry. 2014 Nov 29;14:317.全文  摘要

88. Scahill L, Riddle MA, King RA, et al. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol. 1997 Summer;7(2):75-85. 摘要

89. Rua A, Damásio J. Tics induced by sertraline: case report and literature review. Mov Disord Clin Pract. 2014 Sep;1(3):243-4.

90. Fernández-Alvarez E. Comorbid disorders associated with tics [in Spanish]. Rev Neurol. 2002 Feb;34 (Suppl 1):S122-9. 摘要

91. Kuhn J, Gründler TO, Lenartz D, et al. Deep brain stimulation for psychiatric disorders. Dtsch Arztebl Int. 2010 Feb;107(7):105-13.全文  摘要

92. Nangunoori R, Tomycz ND, Quigley M, et al. Deep brain stimulation for psychiatric diseases: a pooled analysis of published studies employing disease-specific standardized outcome scales. Stereotact Funct Neurosurg. 2013;91(6):345-54.全文  摘要

93. Almeida L, Martinez-Ramirez D, Rossi PJ, et al. Chasing tics in the human brain: development of open, scheduled and closed loop responsive approaches to deep brain stimulation for Tourette syndrome. J Clin Neurol. 2015 Apr;11(2):122-31.全文  摘要

94. Schrock LE, Mink JW, Woods DW, et al; Tourette Syndrome Association International Deep Brain Stimulation (DBS) Database and Registry Study Group. Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord. 2015 Apr;30(4):448-71. 摘要

95. Gilbert DL, Budman CL, Singer HS, et al. A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome. Clin Neuropharmacol. 2014 Jan-Feb;37(1):26-30. 摘要

96. Gabbay V, Babb JS, Klein RG, et al. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder. Pediatrics. 2012 Jun;129(6):e1493-500.全文  摘要

97. Mantovani A, Lisanby SH, Pieraccini F, et al. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive–compulsive disorder (OCD) and Tourette’s syndrome (TS). Int J Neuropsychopharmacol. 2006 Feb;9(1):95-100.全文  摘要

98. Mantovani A, Leckman JF, Grantz H,et al. Repetitive transcranial stimulation of the supplementary motor area in the treatment of Tourette syndrome: report of two cases. Clin Neurophysiol. 2007 Oct;118(10):2314-5. 摘要

99. Münchau A, Bloem BR, Thilo KV, et al. Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology. 2002 Dec 10;59(11):1789-91. 摘要

100. Landeros-Weisenberger A, Mantovani A, Motlagh MG, et al. Randomized sham controlled double-blind trial of repetitive transcranial magnetic stimulation for adults with severe Tourette Syndrome. Brain Stimul. 2015 May-Jun;8(3):574-81.全文  摘要

101. Kluger B, Triolo P, Jones W, et al. The therapeutic potential of cannabinoids for movement disorders. Mov Disord. 2015 Mar;30(3):313-27.全文  摘要

102. Müller-Vahl KR, Schneider U, Prevedel H, et al. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. J Clin Psychiatry. 2003 Apr;64(4):459-65. 摘要

103. Müller-Vahl KR, Schneider U, Koblenz A, et al. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. Pharmacopsychiatry. 2002 Mar;35(2):57-61. 摘要

104. Curtis A, Clarke CE, Rickards HE. Cannabinoids for Tourette's syndrome. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006565.全文  摘要

105. Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009 Dec;67(6):497-501.全文  摘要

106. Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics. 1998 Jul;102(1 Pt 1):14-9. 摘要

107. Groth C, Mol Debes N, Rask CU, et al. Course of Tourette syndrome and comorbidities in a large prospective clinical study. J Am Acad Child Adolesc Psychiatry. 2017 Apr;56(4):304-12. 摘要

108. Debes NM, Lange T, Jessen TL, et al. Performance on Wechsler intelligence scales in children with Tourette syndrome. Eur J Paediatr Neurol. 2011 Mar;15(2):146-54. 摘要

109. Rosenberg LA, Brown J, Singer HS. Behavioral problems and severity of tics. J Clin Psychol. 1995 Nov;51(6):760-7. 摘要

110. Kurlan R, Como PG, Miller B, et al. The behavioral spectrum of tic disorders: a community based study. Neurology. 2002 Aug 13;59(3):414-20. 摘要

111. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology. 2005 Aug 9;65(3):355-9. 摘要

112. Krauss JK, Jankovic J. Severe motor tics causing cervical myelopathy in Tourette's syndrome. Mov Disord. 1996 Sep;11(5):563-6. 摘要